Abstract:Sarah-Eve Lemay 1 , Steeve Provencher 1,2 , Sébastien Bonnet 1,2 , François Potus 1,2 , Olivier Boucherat 1,2 1 Pulmonary Hypertension Research Group, Québec Heart and Lung Institute Research Centre, Québec City, QC, Canada; 2 Department of Medicine, Laval University, Québec City, QC, Canada Comment on: Tai YY, Yu Q, Tang Y, et al . Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension. Sci Transl Med 2024;16:eadd2029. Keywords: Pulmonary arterial hypertension (PAH); vascular remodeling; long non-coding RNA (lncRNA); hypoxia; pulmonary artery endothelial cells (PAECs) Submitted Mar 11, 2024. Accepted for publication Apr 28, 2024. Published online May 28, 2024. doi: 10.21037/atm-24-54 Pulmonary hypertension (PH) encompasses an heterogenous group of disorders, all hemodynamically defined by a mean pulmonary artery (PA) pressure >20 mmHg and characterized by endothelial injury and dysfunction, excessive vasoconstriction, and abnormal vascular remodeling of small PAs (1,2). These changes cause an increase in pulmonary vascular resistance, which ultimately results in right ventricular failure (2). Patients with PH are classified into five groups based upon etiology and mechanism. Although uncommon compared to other forms of PH, pulmonary arterial hypertension (PAH; group 1 PH) is the most severe and best studied subtype (3). Additionally, PH frequently complicates the clinical course of patients with lung diseases and/or hypoxemia, such as chronic obstructive pulmonary disease and interstitial lung disease (group 3 PH). This comorbidity exacerbates the already elevated morbidity and mortality rates associated with these conditions (4). Despite intense research endeavors and Food and Drug Administration (FDA)-approved drugs that mainly target pulmonary vasoconstriction (2,3,5), the prognosis of patients with group 1 and group 3 PH remains poor, emphasizing the urgent need for a better understanding of the molecular mechanisms leading to vascular remodeling. Activation of hypoxia-inducible factors (HIFs) is a hallmark of various subtypes of PH and a driving force in reprogramming the cellular metabolic and epigenetic landscape of PA resident cells (6,7). Among the different oxygen-sensitive alpha subunits, HIF-2α has emerged to play a predominant role in mediating PA endothelial cell (PAEC) proliferation contributing to the development of occlusive intimal/neointimal lesions. Notably, inactivation of HIF-2α targeted to the pulmonary endothelium has been shown to confer protection against chronic hypoxia-induced PH to a greater extent compared to mice with pulmonary endothelial deletion of HIF-1α (8,9). Additionally, pharmacological inhibition of HIF-2α was reported to improve pulmonary vascular remodeling and hemodynamics in several preclinical models of established PH (10). Although HIF-2α is a central protagonist of pulmonary vascular remodeling, the molecular mechanisms mediating its effects and accounting for its upregulation in PAECs remain poorly characterized. Similarly, although the implication of epigenetic changes, such as histone modifications and non-coding RNAs, is gaining increasing attention at the forefront of PH research field, they are still at the beginning. In their recent article published in Science Translational Medicine (11) (summarized in Figure 1 ), Pr. Chan and colleagues provide comprehensive and compelling insights into the intricate relationship between hypoxia and epigenetic events, and its critical impact on metabolic reprogramming that favors PAEC proliferation. As a starting point, the authors identified a long non-coding RNA (lncRNA) called E22 , which was upregulated in the lungs of mice in which PH was induced by the combined exposure to hypoxia and a VEGF receptor antagonist. Interest in this lncRNA was piqued by its conserved syntenic location, positioned head-to-head with the histone lysine N-methyltransferase 2E ( KMT2E ) gene and its partially conserved sequence with human KMT2E-AS1 . Subsequent experiments showed that the increase in E22 , KMT2E-AS1 , and KMT2E transcripts was mainly detected in PAEC of remodeled PAs from both group 1 and group 3 PH patients and PH animal models with preferential nuclear localization. Furthermore, using a bidirectional approach in cultured endothelial cells, HIF-2α was identified as a key regulator of the lncRNA-KMT2E pair. Indeed, depletion of HIF-2α was found to abolish the up-regulation of KMT2E-AS1 and KMT2E transcripts under hypoxia, whereas forced expression of a constitutively active form of HIF-2α in normoxic cells led to opposite effects. Since its nuclear-enriched localization implies a role in chromatin remodeling and trans -Abstract Truncated-

Megakaryocytic Leukemia 1 (mkl1) Ties the Epigenetic Machinery to Hypoxia-Induced Transactivation of Endothelin-1

Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension.

Mrtf-A Steers An Epigenetic Complex To Activate Endothelin-Induced Pro-Inflammatory Transcription In Vascular Smooth Muscle Cells

[A Study on the Regulatory Mechanisms of Mitogen-Activated Protein Kinase Phosphatase-1 in Hypoxia Inducible Factor-1 Trans-Activation].

Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO.

Megakaryocytic Leukemia 1 Bridges Epigenetic Activation of NADPH Oxidase in Macrophages to Cardiac Ischemia-Reperfusion Injury

Role For Mkl1 In Megakaryocytic Maturation

MKL1 mediates TNF-α induced pro-inflammatory transcription by bridging the crosstalk between BRG1 and WDR5.

Myeloid MKL1 Disseminates Cues to Promote Cardiac Hypertrophy in Mice

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma

A HIF-2α-dependent KMT2E-AS1/KMT2E axis orchestrates endothelial epigenetic and metabolic dysfunction in pulmonary hypertension

Endothelin-1 promotes cardiomyocyte terminal differentiation in the developing heart via heightened DNA methylation.

Hypoxia Induces Inflammatory Microenvironment by Priming Specific Macrophage Polarization and Modifies LSC Behaviour Via VEGF-HIF1α Signalling

A Non-Autonomous Role of MKL1 in the Activation of Hepatic Stellate Cells.

FLI1 Mediates the Selective Expression of Hypoxia‐inducible Factor 1 Target Genes in Endothelial Cells under Hypoxic Conditions

MKL1 Fuels ROS-induced Proliferation of Vascular Smooth Muscle Cells by Modulating FOXM1 Transcription

Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

A Molecular Link Between E2F-1 and the MAPK Cascade.

Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway